Last May, the High Court cleared the scheme of arrangement entered by AbbVie to acquire Irish-headquartered Allergan. This week, solicitors from Dublin law firm Matheson were back in the Four Courts – this time in relation to a judicial review of the taxation of the US pharmaceutical multinational in Ireland. The group’s Chicago-headquartered parent, AbbVie Inc, was listed in proceedings with the Revenue Commissioners on Wednesday. The legal action follows a year-long battle with the tax authority over the acquisition of Allergan, which AbbVie agreed in June 2019. The transaction closed last summer when Allergan cancelled its shares and issued…

Want to continue reading?

Introductory offer: Sign up today and pay €200 for an annual membership, a saving of €50.

Subscribe

Cancel at any time.

Are you already a member? .